Glenmark Pharmaceuticals, a prominent global research-led pharmaceutical company with a presence across generic speciality and OTC business, has made a significant announcement regarding disinvestment in its subsidiary company. As detailed in the official report, Glenmark Pharmaceuticals Limited has reached a definitive agreement with Nirma Limited to sell a 75% stake in its subsidiary, Glenmark Life …


